5.18 USD
↗ 0.16 (3.09%)LIVE (AS OF 03:22 PM EDT)
Aardvark Therapeutics, Inc. Common Stock
AARDNASDAQ • USD
Market: OPEN
Aardvark Therapeutics, Inc. Common Stock (AARD) trades at $5.18 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 15, 2026.
Open?$5.04
High?$5.30
Low?$4.95
Prev. Close?$5.02
Volume?33.0K
Avg. Volume?138.4K
VWAP?$5.12
Rel. Volume?0.24x
Bid / Ask
Bid?$4.47 × 100
Ask?$6.10 × 100
Spread?$1.63
Midpoint?$5.29
Valuation & Ratios
Market Cap?109.9M
Shares Out?21.9M
Float?12.1M
Float %?55.5%
P/E Ratio?N/A
P/B Ratio?1.47
EPS?-$3.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Themes
Employees
28
Market Cap
109.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-02-13
Address
4370 LA JOLLA VILLAGE DRIVE
SAN DIEGO, CA 92122
Phone: (858) 225-7696
SAN DIEGO, CA 92122
Phone: (858) 225-7696
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?23
Short Sent.?79
Piotroski F-Score?0/9Weak
Altman Z-Score?5.38Safe
Confidence?36%Very Low
Short InterestModerate
Short % of Float?4.20%Low
Short Interest?509.9K
Days to Cover?3.8
Free Float12.1M
Avg Daily Volume135.1K
Settlement Date2026-08-31
Financial Health
Current Ratio?12.63Strong
Quick Ratio?12.63Strong
Cash Ratio?11.56Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.47CHEAP▾
Peers100
S&P88
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-93.4%WEAK▾
S&P3
ROA?-85.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-69412000
Enterprise Value?$36.0M
Fundamentals ratios updated end of day